Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
51,959,729
-
Share change
-
-3,320,197
-
Total reported value
-
$214,073,531
-
Price per share
-
$4.12
-
Number of holders
-
105
-
Value change
-
-$15,765,845
-
Number of buys
-
51
-
Number of sells
-
59
Institutional Holders of GENMARK DIAGNOSTICS INC - COM (GNMK) as of Q1 2020
As of 31 Mar 2020,
GENMARK DIAGNOSTICS INC - COM (GNMK) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,959,729 shares.
The largest 10 holders included
FMR LLC, MORGAN STANLEY, BlackRock Inc., CADIAN CAPITAL MANAGEMENT, LP, Casdin Capital, LLC, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, Bellevue Group AG, HighTower Advisors, LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
105
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.